~~<i id='5E5858ADAE'><strike id='5E5858ADAE'><tt id='5E5858ADAE'><pre id='5E5858ADAE'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：leisure time 2025-09-30 05:36:14 Page View：4

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Boeing's 1st astronaut flight bumped into next year, more repairs needed
Next article： ChatGPT in medicine: STAT answers readers' burning questions

explore

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

It's time to get medical device identifiers over the finish line

Addingidentifiersformedicaldeviceslikepacemakerstoclaimsformswouldhelpimprovedevicesafety.SEBASTIENB

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

Oak trusses raised to roof of fire

0:38AcraneliftsahugeoakframeatNotreDamedePariscathedral,Tuesday,July11,2023inParis.Thepanelsaredueto